Potentialities of shock wave therapy in the treatment of stable angina
Therapeutic angiogenesis, a new trend in the treatment of IHD has been implemented in cardiology in recent years. Therapeutic angiogenesis includes various approaches of stem cell administration and transmyocardial laser revascularization (TMLR). Novel technologies for noninvasive treatment of angiogenesis in the ischemic area include also shock wave therapy of the heart. Shock wave therapy is indicated primarily in the presence of recurrent angina after myocardial revascularization or hibernating myocardium in patients with postinfarction cardiosclerosis. Ongoing active clinical studies are designed for determining the place of shock wave therapy in the comprehensive treatment of CHF of ischemic genesis and different phases of MI.